News · 26 weeks84-30%
2025-12-142026-06-07
Mix4390d
- Insider23(53%)
- Other9(21%)
- SEC Filings7(16%)
- Analyst2(5%)
- Earnings2(5%)
Latest news
25 items- SECSEC Form SD filed by Henry Schein Inc.SD - HENRY SCHEIN INC (0001000228) (Filer)
- INSIDERNew insider Murphy Kelly Ann claimed ownership of 34,812 shares (SEC Form 3)3 - HENRY SCHEIN INC (0001000228) (Issuer)
- INSIDERAmendment: Former Director Bergman Stanley M gifted 50 shares, decreasing direct ownership by 0.02% to 253,279 units (SEC Form 4)4/A - HENRY SCHEIN INC (0001000228) (Issuer)
- INSIDERDirector Bergman Stanley M gifted 50 shares, decreasing direct ownership by 0.02% to 253,279 units (SEC Form 4)4 - HENRY SCHEIN INC (0001000228) (Issuer)
- SECHenry Schein Inc. filed SEC Form 8-K: Regulation FD Disclosure8-K - HENRY SCHEIN INC (0001000228) (Filer)
- PRHenry Schein Announces the Election of William K. "Dan" Daniel as Independent Chairman of the BoardHenry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced that its Board of Directors has elected William K. "Dan" Daniel as Independent Chairman of the Board, effective May 21, 2026. Mr. Daniel succeeds Stanley M. Bergman, who retired from the Board following 44 years as a Director of Henry Schein and was named Chairman Emeritus in recognition of his extraordinary contributions to the Company. Mr. Daniel joined the Henry Schein Board of Directors in May 2025. He possesses decades of board and global executive leadership experience in healthcare and industrial sectors, including serving for 14
- INSIDERDirector Bergman Stanley M gifted 1,040 shares, decreasing direct ownership by 0.41% to 253,329 units (SEC Form 4)4 - HENRY SCHEIN INC (0001000228) (Issuer)
- PRHenry Schein One Releases 2026 Catalyst Index, Revealing Clinical Performance as the Primary Driver of GrowthTop performers achieve 75% case acceptance vs. 45% industry average, signaling that clinical consistency, not scale alone, drives predictable growth and enterprise value Henry Schein One, the global leader in dental technology, today announced the release of its 2026 Catalyst Index, the fifth edition of its annual benchmarking report analyzing performance across tens of thousands of DSOs, multi-location organizations, and private practices. This year's data points to a clear and urgent shift for the industry: in a slower economy, growth is no longer determined by scale or efficiency alone; it is driven by clinical execution. Across both DSOs and independent practices, the highest-perf
- INSIDERDirector Daniel William K bought $691,900 worth of shares (10,000 units at $69.19) (SEC Form 4)4 - HENRY SCHEIN INC (0001000228) (Issuer)
- SECSEC Form DEFA14A filed by Henry Schein Inc.DEFA14A - HENRY SCHEIN INC (0001000228) (Filer)
- SECSEC Form 10-Q filed by Henry Schein Inc.10-Q - HENRY SCHEIN INC (0001000228) (Filer)
- SECHenry Schein Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - HENRY SCHEIN INC (0001000228) (Filer)
- PRHenry Schein Reports First Quarter 2026 Financial ResultsQ1 2026 GAAP diluted EPS of $0.92 compared to $0.88 GAAP diluted EPS in Q1 2025 Q1 2026 non-GAAP diluted EPS of $1.32 compared to $1.15 non-GAAP diluted EPS in Q1 2025 Reaffirming guidance for 2026 sales, non-GAAP diluted EPS, and Adjusted EBITDA Confirming that value creation initiatives are expected to deliver over $200 million of operating income improvement over the next few years, with $125 million run-rate by year-end 2026 Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the first quarter ended March 28, 2026. "I am pleased with our strong first
- PRHenry Schein to Participate in Upcoming Investor Conferences in MayHenry Schein, Inc., the world's largest provider of healthcare solutions to office-based dental and medical practitioners, announced today that the Company will present at the following conferences in May: Bank of America Healthcare Conference at the Encore Hotel in Las Vegas on May 13, at 2:20 p.m. Pacific time (5:20 p.m. Eastern time) Stifel Jaws & Paws Conference at Lotte Hotel, New York City, on May 27, at 3:00 p.m. Eastern time Henry Schein's presentations can be heard via live webcast by visiting www.henryschein.com/IRwebcasts. Replays will be available on the Henry Schein website following the presentations. About Henry Schein, Inc. Henry Schein, Inc. (NASDAQ:HSIC) is a
- PRDentrix Ascend Introduces Next Generation Clinical Workflow Built with AWSVoice and AI bring charting, imaging, and treatment planning into a single, continuous workflow, helping practices move faster at the chairside and complete more within a single patient visit. Henry Schein One, the global leader in dental technology, today announced the launch of its Next Generation Clinical Workflow, a voice-driven, AI-enabled advancement embedded within the Dentrix Ascend platform that transforms how dentistry is delivered at the chairside. The Next Generation Clinical Workflow represents the next step in Henry Schein One's ongoing collaboration with Amazon Web Services (AWS) to bring generative AI into everyday clinical workflows. The Next Generation Clinical Workflo
- PRDentrix Ascend Opens Its MCP Layer, Bringing AI Agents and a Custom Build Platform to Dental PracticesA new MCP layer gives ambitious practices, DSOs, and developers three ways to work smarter: Ask questions of their data with natural language; run live AI agents that handle operational work automatically; and build custom workflows tailored to how they practice. Henry Schein One, the global leader in dental technology, today announced support for the Model Context Protocol (MCP), an open layer inside Dentrix Ascend that enables ambitious practices, DSOs, and developers to query their data, run AI agents, and build custom workflows, all within the platform they already use. The Platform Dental AI Runs On Henry Schein One supports more than 100,000 global locations, including approxima
- PRHenry Schein to Webcast First Quarter 2026 Conference Call on Tuesday, May 5, 2026, at 8:00 A.M. ETHenry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of healthcare solutions to office-based dental and medical practitioners, announced today that it will release its first quarter 2026 financial results before the stock market opens on Tuesday, May 5, 2026, and will provide a live webcast of its earnings conference call on the same day beginning at 8:00 a.m. Eastern time. Speakers on the call will include Frederick M. Lowery, Chief Executive Officer and Ronald N. South, Senior Vice President and Chief Financial Officer. Investors can access the call by visiting https://investor.henryschein.com/webcasts. A replay will be available on the Henry Schein website following the prese
- ANALYSTBTIG Research initiated coverage on Henry ScheinBTIG Research initiated coverage of Henry Schein with a rating of Neutral
- ANALYSTCitigroup initiated coverage on Henry Schein with a new price targetCitigroup initiated coverage of Henry Schein with a rating of Buy and set a new price target of $100.00
- SECSEC Form DEFA14A filed by Henry Schein Inc.DEFA14A - HENRY SCHEIN INC (0001000228) (Filer)
- SECSEC Form DEF 14A filed by Henry Schein Inc.DEF 14A - HENRY SCHEIN INC (0001000228) (Filer)
- PRHenry Schein to Reduce Size of the Board of Directors following 2026 Annual Meeting of StockholdersStanley M. Bergman to retire from the Board and be named Chairman Emeritus Henry Schein's Board to be reduced to 10 directors following the 2026 Annual Meeting of Stockholders Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of healthcare solutions to office-based dental and medical practitioners, today announced its plan to reduce the size of its Board of Directors following its 2026 Annual Meeting of Stockholders on May 21, 2026. Stanley M. Bergman is to retire from the Board after 44 years as a director of Henry Schein. In recognition of Mr. Bergman's leadership and the significant contributions he has made to the Company, the Board will designate Mr. Bergman Cha
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Henry Schein Inc.SCHEDULE 13G/A - HENRY SCHEIN INC (0001000228) (Subject)
- INSIDERSEC Form 4 filed by Popeck Thomas C4 - HENRY SCHEIN INC (0001000228) (Issuer)
- SECSEC Form 144 filed by Henry Schein Inc.144 - HENRY SCHEIN INC (0001000228) (Subject)
HSIC FAQ
7 questionsWhat does Henry Schein Inc. do?
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates in two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray...Where does HSIC stock trade?
Henry Schein Inc. (HSIC) is listed on NASDAQ.What sector and industry is HSIC in?
Henry Schein Inc. operates in the Health Care sector, Medical Specialities industry.When did Henry Schein Inc. go public?
Henry Schein Inc. (HSIC) completed its IPO in 1995.What are analysts saying about HSIC?
Henry Schein Inc. has had 8 recent analyst actions on file. The most recent action was from BTIG Research: Neutral on 2026-04-16.What companies are similar to HSIC?
Notable peers in the same industry include MCK (McKesson Corporation), PDCO (Patterson Companies Inc.), XRAY (DENTSPLY SIRONA Inc.). Compare HSIC side-by-side with any of them on Quantisnow.How can I track HSIC on Quantisnow?
Quantisnow aggregates Henry Schein Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow HSIC to receive live email and push alerts on every new disclosure.